Medtronic

Greater private-public partnerships needed to fix the mismatch between patient needs and the current focus of healthtech firms.

SINGAPORE (May 22): QT Vascular is in talks with interested third parties for possible transactions involving its coronary products.

SINGAPORE (March 22): Catalist-listed QT Vascular says a New York-based private alternative investment group, GEM Global Yield Fund, has agreed to provide it with up to $10 million in capital commitment over the next 30 months.